The 3rd annual ViE Awards

Vaccine Industry Excellence (ViE) Asia Awards have been created to honour and generate public recognition of the efforts, accomplishments, and positive contributions of organisations and individuals in Asia’s vaccine industry. Our mission is to identify and reward those organisations and individuals who have demonstrated an unparalleled ability to succeed, continually set standards of excellence, and who will be the future stars of the industry.

ViE Asia Awards is the time for the industry to come together and recognise their peers who have set themselves apart and have exhibited outstanding performance. With 7 distinguished categories, there is an opportunity for all types of organisations to get involved. Take this opportunity to nominate and vote for the most deserving organisations and individual!

Sponsor or exhibit at World Vaccine Congress Asia 2012 ›

Nominate now ›

The 3rd annual ViE Awards at World Vaccines Congress Asia 2012 
 

The ViE Awards ceremony and gala dinner 

The 3rd annual Vaccine Industry Excellence Awards, taking place on the evening of the 12 June will be an integral part of World Vaccine Congress Asia 2012.

In 2012, the awards ceremony and gala dinner will provide guests with the perfect opportunity to network with clients and prospects.

Our mission is identify and reward those companies and individuals who have demonstrated an unparalleled ability to succeed and to continually set standards of excellence.
 

become a sponsor ›

Why enter the ViE Awards?

CEOs of many FTSE and Fortune 500 companies have discovered the strategic advantages of entering and winning corporate awards.

Boardrooms across the globe are seeing the advantages of being shortlisted or winning an industry award.

ViE awards can help:

  • Position your company as a leader in its field
  • Increase your visibility and profile in the marketplace
  • Help strengthen your marketing, IR and PR
  • Attract, recruit and retain new talent

become a sponsor ›

 

Developing effective production strategies for multi-vaccine manufacturing in Asia

  • Evaluating specific challenges associated with manufacturing different vaccines
  • Developing robust approaches to fully utilise production facility
  • Exploring the different strategies available for ensuring quality control and regulatory compliance

Growing vaccine pipeline value through effective partnering and investment strategies in Asia

Asia contains a wide variety of vaccine markets, each with different advantages due to cultural, economic and geographic differences. Identifying the right partners to develop vaccines from initial R&D through trials to commercialization requires a strategic and well defined approach.
This workshop will assist participants in understanding how to approach the Asian market for external research and development and how to successfully build a pipeline through strategic partnerships.

Transitioning existing biologics processes into single use technology platform to enable global deployment

  • Factors to consider before implementation: performance equivalency, quality, logistics and business needs
  • Evaluating which single-use equipment to utilize, considering cost and which stage should be implemented first
  • Examining before and after implementation for optimum efficiency

Optimising cost-effective Japanese Encephalitis (JE) vaccine development in Asia

  • Evaluating current development on inactivated and live molecular JE vaccine for the global population
  • Tapping on lessons learnt from producing the vaccine in Asia
  • Case study: Assessing the long term immunity of live attenuated Japanese encephalitis chimeric virus vaccine

Innovative vaccine design: Important chemistry, manufacturing and controls (CMC) issues in adjuvant development

  • Uncovering new concepts and knowledge about innovative vaccine design; innate immunity and beyond
  • Tapping on advanced technologies of immune-manipulation and delivery system in Japan
  • Overcoming regulatory hurdles and harnessing the potential for adjuvants in Japan; key factors for very safe and efficacious vaccines

Innovative International Vaccine Developments

Leading global and Asian biotechs, pharmas and research institutes will showcase their latest vaccine developments looking for potential partners globally and across Asia. Potential partnerships run from research and development to licensing and collaboration in vaccine commercialization.

sponsor World Vaccine Congress Asia 2012 ›

Sponsors
Platinum sponsor
GE Healthcare at World Vaccine Congress Asia 2012
Gold Sponsor
Merck Millipore at World Vaccine Congress Asia 2012
Silver Sponsor
Medicago Inc at World Vaccine Congress Asia 2012
Bronze sponsor
Finesse Solutions, LLC at World Vaccine Congress Asia 2012
Bronze Sponsor
ViroClinics Biosciences B.V. at World Vaccine Congress Asia 2012
Innovative showcase sponsor
Bavarian Nordic A/S at World Vaccine Congress Asia 2012
Innovative biotech showcase sponsor
Immune Targeting Systems (ITS) Ltd at World Vaccine Congress Asia 2012

sponsors list ›